GLP-1 Boom: One in Eight U.S. Adults Now Taking Drugs, Driving Manufacturing and Consumer Shifts
One in eight U.S. adults now takes a GLP-1, and prescriptions among non-diabetics rose 700% since 2019. The market is projected to reach $200 billion by 2030, driving manufacturing investments and consumer food shifts.